In vivo CAR T cell generation to treat cancer and autoimmune disease
Science · 19.06.2025 · 388 (6753) · 1311-1317
DOI: 10.1126/science.ads8473 ↗Kurz gefasst
Fachartikel in der Zeitschrift Science, erschienen am 19.06.2025. Verfasst von Theresa L Hunter und 39 weiteren Autor:innen. Beteiligte Einrichtung: Capstan Therapeutics, San Diego, CA, USA. Hauptthemen laut MEDLINE: Autoimmune Diseases, CD8-Positive T-Lymphocytes, Immunotherapy, Adoptive, Lymphocyte Depletion. Die Arbeit wurde bisher 383-mal zitiert (Crossref) und nennt 41 Literaturangaben.
Abstract (Originalsprache)
Chimeric antigen receptor (CAR) T cell therapies have transformed treatment of B cell malignancies. However, their broader application is limited by complex manufacturing processes and the necessity for lymphodepleting chemotherapy, restricting patient accessibility. We present an in vivo engineering strategy using targeted lipid nanoparticles (tLNPs) for messenger RNA delivery to specific T cell subsets. These tLNPs reprogrammed CD8 + T cells in both healthy donor and autoimmune patient samples, and in vivo dosing resulted in tumor control in humanized mice and B cell depletion in cynomolgus monkeys. In cynomolgus monkeys, the reconstituted B cells after depletion were predominantly naïve, suggesting an immune system reset. By eliminating the requirements for complex ex vivo manufacturing, this tLNP platform holds the potential to make CAR T cell therapies more accessible and applicable across additional clinical indications.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Capstan Therapeutics, San Diego, CA, USA.
- Muscle Disease Section, National Institute of Arthritis and Musculoskeletal and Skin Diseases, National Institutes of Health, Bethesda, MD, USA.
- Center for Cellular Immunotherapies, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA, USA.
- Department of Pathology and Laboratory Medicine, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA, USA.
- Parker Institute for Cancer Immunotherapy at the University of Pennsylvania, Philadelphia, PA, USA.
ORCID-Profile: Theresa L Hunter, Yanjie Bao, Romina Riener, Annabel Wang, Ferran Soldevila, Duy P Nguyen, Brittany Ross, Michelle Nguyen, James Vestal, Diana Galvan, Jerel Boyd Vega, Josephine Nguyen, Claudia Fernandez, Jeffrey Chen, E Michael Pica, Andrew L Mammen, John Scholler, Steven P Tanis, Stuart A Sievers, Aric M Frantz, Laura Shawver, Carl H June, Haig Aghajanian
Zitieren
APA
Hunter, T. L., Bao, Y., Zhang, Y., Matsuda, D., Riener, R., Wang, A., Li, J. J., Soldevila, F., Chu, D. S. H., Nguyen, D. P., Yong, Q. C., Ross, B., Nguyen, M., Vestal, J., Roberts, S., Galvan, D., Vega, J. B., Jhung, D., Butcher, M., …, & Aghajanian, H. (2025). In vivo CAR T cell generation to treat cancer and autoimmune disease. Science, 388(6753), 1311-1317. https://doi.org/10.1126/science.ads8473
Vancouver
Hunter TL, Bao Y, Zhang Y, Matsuda D, Riener R, Wang A, et al. In vivo CAR T cell generation to treat cancer and autoimmune disease. Science. 2025;388(6753):1311-1317. doi:10.1126/science.ads8473
BibTeX
@article{Hunter2025,
author = {Hunter, Theresa L and Bao, Yanjie and Zhang, Yan and Matsuda, Daiki and Riener, Romina and Wang, Annabel and Li, John J and Soldevila, Ferran and Chu, David S H and Nguyen, Duy P and Yong, Qian-Chen and Ross, Brittany and Nguyen, Michelle and Vestal, James and Roberts, Scott and Galvan, Diana and Vega, Jerel Boyd and Jhung, Donald and Butcher, Matthew and Nguyen, Josephine and Zhang, Stanley and Fernandez, Claudia and Chen, Jeffrey and Herrera, Carolina and Kuo, Yi and Pica, E Michael and Mondal, Goutam and Mammen, Andrew L and Scholler, John and Tanis, Steven P and Sievers, Stuart A and Frantz, Aric M and Adams, Gregor B and Shawver, Laura and Farzaneh-Far, Ramin and Rosenzweig, Michael and Karmali, Priya P and Bot, Adrian I and June, Carl H and Aghajanian, Haig},
title = {In vivo CAR T cell generation to treat cancer and autoimmune disease},
journal = {Science},
year = {2025},
volume = {388},
number = {6753},
pages = {1311--1317},
doi = {10.1126/science.ads8473}
}
EUVIMED